(Q53362480)

13 May 2018

title

Serum peptides as candidate biomarkers for dementia with Lewy bodies. (English)

1 reference

13 May 2018

0 references

0 references

Itsuku Suzuki

1

1 reference

13 May 2018

Miwa Noguchi

2

1 reference

13 May 2018

Mitsumi Arito

3

1 reference

13 May 2018

Toshiyuki Sato

4

1 reference

13 May 2018

Kazuki Omoteyama

5

1 reference

13 May 2018

Mioto Maedomari

6

1 reference

13 May 2018

Hiroshi Hasegawa

7

1 reference

13 May 2018

Naoya Suematsu

8

1 reference

13 May 2018

Kazuki Okamoto

9

1 reference

13 May 2018

Tomohiro Kato

10

1 reference

13 May 2018

Noboru Yamaguchi

11

1 reference

13 May 2018

Manae S Kurokawa

12

1 reference

13 May 2018

language of work or name

English

0 references

publication date

6 March 2015

1 reference

13 May 2018

International Journal of Geriatric Psychiatry

published in

1 reference

13 May 2018

volume

30

1 reference

13 May 2018

issue

12

1 reference

13 May 2018

page(s)

1195-1206

1 reference

13 May 2018

CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

cites work

1 reference

Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?

21 January 2018

1 reference

Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease

21 January 2018

1 reference

CSF neurofilament proteins in the differential diagnosis of dementia

21 January 2018

1 reference

Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies

21 January 2018

1 reference

Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease

21 January 2018

1 reference

Protein profiles of peripheral blood mononuclear cells are useful for differential diagnosis of ulcerative colitis and Crohn's disease

21 January 2018

1 reference

Addition of MHPG to Alzheimer's disease biomarkers improves differentiation of dementia with Lewy bodies from Alzheimer's disease but not other dementias

21 January 2018

1 reference

Structural biology of the LPS recognition

21 January 2018

1 reference

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

21 January 2018

1 reference

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

Tau protein, Abeta42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies

21 January 2018

1 reference

Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration

21 January 2018

1 reference

Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: marker candidates for dementia with Lewy bodies

21 January 2018

1 reference

Roles of serum fibrinogen α chain-derived peptides in Alzheimer's disease.

21 January 2018

1 reference

Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?

21 January 2018

1 reference

Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.

21 January 2018

1 reference

Mild cognitive impairment: clinical characterization and outcome

21 January 2018

1 reference

Heart fatty acid binding protein as a potential diagnostic marker for neurodegenerative diseases.

21 January 2018

1 reference

Glial involvement in the degeneration process of Lewy body-bearing neurons and the degradation process of Lewy bodies in brains of dementia with Lewy bodies

21 January 2018

1 reference

Serum proteomic profiling of dementia with Lewy bodies: diagnostic potential of SELDI-TOF MS analysis

21 January 2018

1 reference

Gene expression profiling in developing human hippocampus

21 January 2018

1 reference

Dementia with Lewy bodies

21 January 2018

1 reference

Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders.

21 January 2018

1 reference

7 January 2021

Degeneration process of Lewy bodies in the brains of patients with dementia with Lewy bodies using alpha-synuclein-immunohistochemistry

1 reference

7 January 2021

Serum heart-fatty acid binding protein levels in patients with Lewy body disease

1 reference

7 January 2021

Plasma levels of DJ-1 as a possible marker for progression of sporadic Parkinson's disease

1 reference

7 January 2021

Identifiers

DOI

10.1002/GPS.4274

1 reference

13 May 2018

1 reference

13 May 2018